Investor’s Toolkit: Key Ratios for Assessing Teva- Pharmaceutical Industries Ltd. ADR (TEVA)’s Performance

For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) closed the day trading at $21.30 down -3.36% from the previous closing price of $22.04. In other words, the price has decreased by -$3.36 from its previous closing price. On the day, 7.36 million shares were traded. TEVA stock price reached its highest trading level at $22.3 during the session, while it also had its lowest trading level at $21.255.

Ratios:

For a better understanding of TEVA, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.28 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 8.82. For the most recent quarter (mrq), Quick Ratio is recorded 0.61 and its Current Ratio is at 0.89. In the meantime, Its Debt-to-Equity ratio is 3.18 whereas as Long-Term Debt/Eq ratio is at 2.75.

On March 08, 2024, JP Morgan Upgraded its rating to Neutral which previously was Underweight but kept the price unchanged to $14.

Piper Sandler Upgraded its Neutral to Overweight on February 12, 2024, whereas the target price for the stock was revised from $12 to $19.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 20 ’24 when MIGNONE ROBERTO sold 286,000 shares for $22.01 per share. The transaction valued at 6,294,031 led to the insider holds 695,000 shares of the business.

Bridger Management, LLC (1) bought 286,000 shares of TEVA for $6,094,660 on Dec 20 ’24. On Nov 20 ’24, another insider, Fox Christine, who serves as the EVP, Head of U.S. Commercial of the company, sold 19,388 shares for $16.87 each. As a result, the insider received 327,085 and left with 44,104 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TEVA now has a Market Capitalization of 24892243968 and an Enterprise Value of 40408969216. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.44 while its Price-to-Book (P/B) ratio in mrq is 3.98. Its current Enterprise Value per Revenue stands at 2.409 whereas that against EBITDA is 8.443.

Stock Price History:

Over the past 52 weeks, TEVA has reached a high of $22.80, while it has fallen to a 52-week low of $10.45. The 50-Day Moving Average of the stock is 15.64%, while the 200-Day Moving Average is calculated to be 25.76%.

Shares Statistics:

Over the past 3-months, TEVA traded about 8.21M shares per day on average, while over the past 10 days, TEVA traded about 10465090 shares per day. A total of 1.13B shares are outstanding, with a floating share count of 1.13B. Insiders hold about 0.01% of the company’s shares, while institutions hold 56.88% stake in the company. Shares short for TEVA as of 1734048000 were 23220122 with a Short Ratio of 2.83, compared to 1731628800 on 21191235. Therefore, it implies a Short% of Shares Outstanding of 23220122 and a Short% of Float of 2.0599999.

Dividends & Splits

The stock’s 5-year Average Dividend Yield is 2.95.

Most Popular